January 25, 2005 -- Before the opening bell, four drug companies reported Q4 earnings today three of them card-carrying members of the big pharma group. The upshot? Two companies are still making money in fact, a lot of money while the others are looking forward to a more profitable future. Perhaps the takeaway from the announcements is that the drug business remains a very good business for most of these companies it’s the worries about the future that keeps their prices from rising. We look at the numbers for J&J, Merck, Schering-Plough and Cubist...
